Stay updated on Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial

Sign up to get notified when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Posted trial results and updated study record dates were added to the page (Results First Posted 2024-11-14; Study Record Dates Updated 2024-11-14).
    Difference
    0.0%
    Check dated 2026-04-03T06:00:39.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Results data was added to the study page, including a 'Results First Posted' date (2024-11-14). Study record dates were updated accordingly.
    Difference
    0.0%
    Check dated 2026-03-27T02:36:21.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T23:56:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T20:24:16.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.1 to v3.4.2 with no observable changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:53:50.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no user-facing content or functionality on the Study Details page appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:46:17.000Z thumbnail image

Stay in the know with updates to Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tabelecleucel & Pembrolizumab in EBV+ NPC Clinical Trial page.